Last Updated:
Access Report
Name Designation Appointment Date Status
Pinkalbhai Harshwardhan Sanghavi

Appointed as Director since October 2020

 Director 20-Oct-2020 Current
Name Designation Appointment Date Status
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Dinesh yadav Director 10-june-2021 current
Pravinkumar Bababhai Patel

Appointed as Director since October 2020

 Director 20-Oct-2020 Current

People Timeline

Explore the timeline of key personnel in Gleam Bulk Drug Research Foundation's leadership journey.

Contact Details
  • Address 4/B Block,Harsiddhapart.,Nr.Aditi Societ Bh Umiyahall,Nr Mandakiniflats,Ghatlodia, Ahmedabad Gujarat, 380061, India
  • Telephone Upgrade
  • Email Upgrade
  • Pin Code 380061
  • Country India
  • Website -
Frequently Asked Questions
How can I contact Gleam Bulk Drug Research Foundation?
You can contact Gleam Bulk Drug Research Foundation through their registered address at 4/B Block,Harsiddhapart.,Nr.Aditi Societ Bh Umiyahall,Nr Mandakiniflats,Ghatlodia, Ahmedabad Gujarat, 380061, India, or via their website if available. Social media links are also provided where applicable.
Who are the current directors of Gleam Bulk Drug Research Foundation?
The current directors of Gleam Bulk Drug Research Foundation are listed above in the "Current Directors & Signatories" section. You can view their names, designations, and appointment dates.
  • PINKALBHAI HARSHWARDHAN SANGHAVI
  • PRAVINKUMAR BABABHAI PATEL
How can I access past director details?
Past director details are available under the "Past Directors & Signatories" tab. You may need to upgrade your subscription to view detailed information.
Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available